Skip to main content

Featured Studies

Office of Patient Recruitment

This web page makes it easy to search for featured research studies at the NIH Clinical Center. You can search for specific studies by entering keywords related to your symptoms in the search box or by using the sort and filter options.


To view a full list of all studies conducted at the NIH Clinical Center, visit Search the Studies.

Filter By

Visit Type

Patient or Healthy Volunteer

Age Group

Web Page Language

3 results
Study of Systemic Lupus Erythematosus

Study of Systemic Lupus Erythematosus

The National Institutes of Health (NIH) is conducting a research study for patients with lupus. Doctors want to learn more about the disease and are looking for what causes it, how it progresses over time, and the genetic factors that might make a person more likely to develop it. This study is open to any individual, 10 years of age or older, who meets the American College of Rheumatology's criteria for having lupus, which include symptoms and abnormal blood tests.

Learn More
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

The National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health (NIH) in Bethesda, Maryland is conducting a study for vasculitis. Researchers are inviting both volunteers who have the condition, and those who do not, to participate in this study. All study-related tests and procedures are provided at no cost to you.

Learn More
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients with Systemic Lupus Erythematosus

People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. The risks increase for heart attacks or stroke. No medications have been effective at reducing this risk in people with lupus. Researchers at NIH are testing whether a drug (anifrolumab) can improve blood vessel function and reduce blood vessel inflammation in people with (SLE). Participants do not pay for tests, treatments, or procedures.
Learn More
Was this page helpful?